1-15 of 15
Wenyuan MAI
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

Free
Shanshan Suo, Ying Lu, Wenjuan Yu, Chunmei Yang, Lijing Shen, Renzhi Pei, Beiwen Ni, Wanzhuo Xie, Liping Mao, Xingnong Ye, Jiejing Qian, Jin Wang, Bingzong Li, Xiaomin Wang, Linjie Li, Dan Zhao, Yongming Xia, Lihong Shou, Yanping Shao, Da Gao, Wenyuan Mai, De Zhou, Gaixiang Xu, Min Yang, Yinjun Lou, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 836.
https://doi.org/10.1182/blood-2024-208355
Published: 2024
Journal Articles

Practical Application of Orelabrutinib in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Analysis of Real-World Evidence (OCARE Study)

Free
Xuewu Zhang, Haitao Meng, Gaixiang Xu, Min Yang, Wanzhuo Xie, Juying Wei, Liya Ma, Xingnong Ye, Liping Mao, Wenyuan Mai, Chunmei Yang, Yanling Ren, Hongyan Tong, Yanan Zhu, Xiang Zhang, Jie Jin, Wenjuan Yu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6772.
https://doi.org/10.1182/blood-2024-203639
Published: 2024
Journal Articles

Construction and Evaluation of a Prognostic Model for Patients with Acute Myeloid Leukemia

Free
Feng Zhu, Yile Zhou, Yi Zhang, Wanzhuo Xie, Haitao Meng, Wenjuan Yu, Liping Mao, Jian Huang, Wenyuan Mai, Chunmei Yang, Juying Wei, Yinjun Lou, Min Yang, Jiejing Qian, Gaixiang Xu, De Zhou, Liya Ma, Xingnong Ye, Yanling Ren, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 6144.
https://doi.org/10.1182/blood-2024-209459
Published: 2024
Journal Articles

Orelabrutinib Combined with Bendamustine-Rituximab or Obinutuzumab Followed By Orelabrutinib Maintenance Therapy for Untreated Marginal Zone Lymphoma (MZL): A Prospective ,Multicenter, Clinical Study（Optimize Study）

Free
Xuewu Zhang, Yanan Zhu, Xiang Zhang, Xingnong Ye, Gaixiang Xu, Liya Ma, Yanling Ren, Liping Mao, Min Yang, Chunmei Yang, Juying Wei, Yinjun Lou, Wenyuan Mai, Wanzhuo Xie, Haitao Meng, Hongyan Tong, Jie Jin, Wenjuan Yu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6280.
https://doi.org/10.1182/blood-2024-204442
Published: 2024
Journal Articles

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Free
Feng Zhu, Nianci Chen, Yile Zhou, Yi Zhang, Jian Huang, Wanzhuo Xie, Haitao Meng, Wen-Juan Yu, Liping Mao, Wenyuan MAI, Chunmei Yang, Juying Wei, Yinjun Lou, Min Yang, Jiejing Qian, Gaixiang Xu, De Zhou, Liya Ma, Xingnong Ye, Yanling Ren, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6001.
https://doi.org/10.1182/blood-2023-186048
Published: 2023
Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial

Free
Shanshan Suo, Wen-Juan Yu, Ying Lu, Jiejing Qian, Liping Mao, Jin Wang, Lijing Shen, Bingzong Li, Huafeng Wang, Wenyuan MAI, Wanzhuo Xie, Xiaomin Wang, Dan Zhao, Yuanfang Liu, Chuan He, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2869.
https://doi.org/10.1182/blood-2023-191190
Published: 2023
Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Free
Huafeng Wang, Liping Mao, Wanzhuo Xie, Hongyan Tong, Min Yang, Gaixiang Xu, Xiujin Ye, Ying Lu, Juying Wei, Wenyuan Mai, De Zhou, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2334.
https://doi.org/10.1182/blood-2021-153257
Published: 2021
Journal Articles

A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia

Free
Jiejing Qian, Jieyu Xu, Qing Hong, Yinjun Lou, Liping Mao, Weilai Xu, Min Yang, Wenjuan Yu, Haitao Meng, Wenyuan Mai, Xiujing Ye, Honghu Zhu, Jie Jin
Journal: Blood
Blood (2021) 138 (Supplement 1): 4414.
https://doi.org/10.1182/blood-2021-149523
Published: 2021
Journal Articles

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Free
Jinghan Wang, PhD, Zhixin Ma, PhD, Qinrong Wang, Mengxia Yu, PhD, Xiufeng Yin, PhD, Xia Li, PhD, Shanshan Suo, Dan Shen, Yungui Wang, PhD, Xin Huang, Hanzhang Pan, Huanping Wang, Zhimei Chen, MD, Jiansong Huang, PhD, Liping Mao, Wenjuan Yu, MD, Juying Wei, MD, Wenbin Qian, Wenyuan Mai, MD, Haitao Meng, MD, Hongyan Tong, MD, Suning Chen, Guido Marcucci, MD, Saijuan Chen, Jie Jin, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5058.
https://doi.org/10.1182/blood.V128.22.5058.5058
Published: 2016
Journal Articles

Homoharringtonine in Combination with Cytarabine and Aclarubicin in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia: a Single-Center Experience

Free
Wenjuan Yu, MD, Liping Mao, MD, Jiejing Qian, MD, Wenbin Qian, MD, Haitao Meng, MD, Wenyuan Mai, MD, Hongyan Tong, MD, Yin Tong, MD, Jie Jin, MD
Journal: Blood
Blood (2011) 118 (21): 2595.
https://doi.org/10.1182/blood.V118.21.2595.2595
Published: 2011
Journal Articles

Clinical Characteristics of T-Cell Lymphoma Associated Hemophagocytic Syndrome: Comparison of T-Cell Lymphoma with and without Hemophagocytic Syndrome.

Free
Hongyan Tong, MD, PhD, Yanling Ren, MD, Feng Xiao, MD, Wenyuan Mai, MD, PhD, Haitao Meng, MD, PhD, Wenbin Qian, MD, PhD, Jie Jin, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3576.
https://doi.org/10.1182/blood.V110.11.3576.3576
Published: 2007
Journal Articles

Prevention of Homoharringtonine Induced Apoptosis by Antioxidants in K562 Cells.

Free
Wenyuan Mai, MD, PhD, Maofang Lin, MD
Journal: Blood
Blood (2006) 108 (11): 4378.
https://doi.org/10.1182/blood.V108.11.4378.4378
Published: 2006
Journal Articles

Retrospective Study on T Cell Malignent Lymphoma: Classification, Manifestation, Laboratory Finding and Survival.

Free
Hongyan Tong, MD, PhD, Feng Xiao, MD, Tieying Dai, MD, Jie Jin, MD,PhD, Haitao Meng, MD,PhD, Wenbing Qian, MD,PhD, Wenyuan Mai, MD,PhD, Fengjuan Zhang, MD, Hui Liu, MD
Journal: Blood
Blood (2006) 108 (11): 4652.
https://doi.org/10.1182/blood.V108.11.4652.4652
Published: 2006
Journal Articles

Homoharringtonine Based Triple-Drug Regimen as Induction Chemotherapy for De Novo Acute Myelogenous Leukemia.

Free
Jie Jin, Wenbin Qian, Hui Liu, Daozi Jian, Wenyuan Mai, Hongyan Tong, Haitao Men
Journal: Blood
Blood (2006) 108 (11): 2002.
https://doi.org/10.1182/blood.V108.11.2002.2002
Published: 2006
Journal Articles

Effect of Homoharringtonine on Differentiation and Apoptosis of Human Leukemic Cell.

Free
Wenyuan Mai, MD, PhD, Maofang Lin, MD
Journal: Blood
Blood (2005) 106 (11): 4425.
https://doi.org/10.1182/blood.V106.11.4425.4425
Published: 2005